| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.07 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 0.07 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.07 |